Schluter, Jonas http://orcid.org/0000-0002-6214-9367
Peled, Jonathan U. http://orcid.org/0000-0002-4029-7625
Taylor, Bradford P.
Markey, Kate A.
Smith, Melody http://orcid.org/0000-0002-2702-0381
Taur, Ying
Niehus, Rene http://orcid.org/0000-0002-6751-4124
Staffas, Anna
Dai, Anqi
Fontana, Emily
Amoretti, Luigi A.
Wright, Roberta J.
Morjaria, Sejal
Fenelus, Maly
Pessin, Melissa S. http://orcid.org/0000-0003-3990-6494
Chao, Nelson J.
Lew, Meagan
Bohannon, Lauren
Bush, Amy
Sung, Anthony D.
Hohl, Tobias M. http://orcid.org/0000-0002-9097-5412
Perales, Miguel-Angel http://orcid.org/0000-0002-5910-4571
van den Brink, Marcel R. M. http://orcid.org/0000-0003-0696-4401
Xavier, Joao B. http://orcid.org/0000-0003-3592-1689
Article History
Received: 3 May 2019
Accepted: 30 September 2020
First Online: 25 November 2020
Competing interests
: M.R.M.v.d.B. and J.U.P. received financial support from Seres Therapeutics. M.-A.P. has received honoraria from AbbVie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, and Takeda, research support for clinical trials from Incyte, Kite (Gilead) and Miltenyi Biotec, and serves on data and safety monitoring boards for Servier and Medigene and scientific advisory boards for MolMed and NexImmune.